Phillippe Spiess, M.D.

Phillippe Spiess M.D.

Assistant Professor
Department of Oncologic Sciences
USF College of Medicine

Latest Publications:

Spiess, P.E., Tannir, N.M., Brown, G.A., Liu, P., Tu, S.M., Evans, J.G., Pisters, L.L.: Recurrence in NSGCT patients with no viable tumor at PC-RPLND. Urology, In Press

Spiess, P.E., Tannir, N.M., Tu, S.M., Brown, G.A., Liu, P., Kamat, A.M., Wood, C.G., Evans, J.G., Pisters, L.L.: Viable germ cell tumor at post-chemotherapy RPLND: Can we predict who’s at risk of progression? Cancer, In Press

Spiess, P.E., Pettaway, C.A., Vakar-Lopez, F., Kassouf, W., Wang, X., Busby, J.E., Do, K.A., Davuluri, R., Tannir, N.M.: Treatment outcomes of small cell carcinoma of the prostate: A single center study. Cancer, In Press

Spiess, P.E., Busby, J.E., Jordan, J., Steinberg, J.R., Bassett, R., Burt, K., Troncoso, P., Lee, A.K., Taylor, S., Pisters, L.L.: Ability of DRE and TRUS biopsies to predict the side of nodal metastases in prostate cancer. Urologic Oncology, In Press

Leibovici, D., Spiess, P.E., Heller, L., Rodriguez-Bigas, M., Chang, G., Pisters, L.L.: Salvage surgery for locally recurrent prostate following radiation therapy: Tricks of the trade. Urologic Oncology, In Press

Spiess, P.E., Brown, G.A., Pisters, L.L., Campbell, K., Liu, P., Pettaway, C.A., Gomez, J.A., Kamat, A.M., Kassouf, W., Tannir, N.M.: Malignant transformation of testicular teratoma: A chemoresistant phenotype. Urologic Oncology, In Press

Leibovici, D., Spiess, P.E., Lee, A.K., Pisters, L.L.: Symptomatic Local Recurrence of Prostate Cancer after Radiation Therapy: Lessons Learned from 1006 Patients Treated at M. D. Anderson Cancer Center. Amer J Oncol Res, In press

Education & Training:

• Fellowship, University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - Urologic Oncology
• Residency, McGill University, Montreal, Canada, 2004 - Urology
• MD, University of Toronto, Ontario, Canada, 1999
• MS, McGill University, Montreal, Canada, 1995 - Experimental Surgery, Urology

General Board Certification / SubSpecialty:

• Urology
• Surgery

Research Interests:

My main areas of research interests include developing novel therapeutic agents in the management of locally advanced and metastatic renal carcinoma. As well, I have interests in developing multi-modality therapeutic strategies in the management of locally advanced and locally recurrent prostate cancer, with the aim of optimizing treatment outcomes while minimizing morbidity.